Teva Shares Plunge as CEO Steps Down From Israeli Pharmaceutical Giant – The Forward
Ex-pharmaceutical company boss faces insider trading charges over Teva deal | The Times of Israel
Buffett's Berkshire Hathaway doubles shares of Teva - JNS.org
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva's $40.5B record deal
Teva shed 37% of Israel workforce in two years - Globes
Israel Not Aiming to Punish Teva on Job Cuts, Official Says - Bloomberg
Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
Israel Fights Back on Teva Job Cuts - WSJ
Teva Pharmaceutical Industries Ltd. – Artonpapers
Teva Stock: What We Know, And Don't, About The Adderall Shortage | Investor's Business Daily
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Stock Price Rises - Wise Money Israel
Why Warren Buffett's Berkshire loves loathed Israeli drug stock Teva
Teva stock gains on new growth strategy; Evercore upgrades | Seeking Alpha
Teva's Stock Price Surge Against Its Predictable Woes
Teva's shares surge as first quarter results beat expectations | The Times of Israel
Teva Falls Hard, Loses Title as Israel's Biggest Firm - TheStreet
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Opioid lawsuit concerns hit Teva - Globes
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/UYYIWER3TJHUVEUM444ZBHVWGM.jpg "Teva stock falls in Israel and New York as CEO says 2018 will be a year of falling sales and profits")
Teva stock falls in Israel and New York as CEO says 2018 will be a year of falling sales and profits
Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Several ESG Targets Ahead of Schedule | Business Wire
